对TME敏感的纳米复合水凝具有针对性能力,用于增强MYC增强骨髓肉瘤的协同化学免疫疗法
Yichao Ma1, Peng Lai1, Zhou Sha2
1Department of Orthopedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China.
Bioactive materials
|February 3, 2025
概括
这项研究开发了一种针对MYC增强骨髓瘤的新型水凝疗法. 它有效地针对MYC和瘤微环境,增强抗瘤免疫力并减少转移.
科学领域:
- 生物医学工程 生物医学工程
- 在瘤学瘤学.
- 纳米技术 纳米技术
背景情况:
- 在骨髓瘤中,MYC放大是常见的,导致不良结果.
- 目前对MYC增强骨髓瘤的治疗方法在很大程度上是无效的,原因是免疫抑制.
- 针对MYC和瘤微环境是有效治疗的关键.
研究的目的:
- 开发一种可注射的,对瘤微环境 (TME) 敏感的纳米复合材料水凝.
- 同时提供一个MYC抑制剂 (NHWD-870) 和针对IL11Rα (Cis/Mn@Lipo-IL11) 的西斯普拉丁装载脂质体.
- 研究对MYC下调,免疫细胞死亡 (ICD) 诱导和抗瘤免疫的协同效应.
主要方法:
- 开发一种纳米复合材料水凝,用于同时输送NHWD-870和Cis/Mn@Lipo-IL11.
- 在现场给药和MYC降解和细胞因子调节的评估.
- 评估活性氧物种 (ROS) 生成,ICD诱导和巨细胞激活.
- 在骨髓瘤模型中分析免疫细胞透,瘤生长抑制和转移减弱.
主要成果:
- 水凝成功地输送了两种治疗剂,降解了MYC和调节细胞因子以激活M1巨细胞.
- Cis/Mn@Lipo-IL11产生ROS并释放西斯,诱导ICD并促进树突细胞成熟.
- 结合疗法重塑了免疫微环境,增强了T细胞透.
- 在体内观察到显著的瘤生长抑制和减少的肺转移.
结论:
- 开发的纳米复合液凝为MYC增强骨髓瘤的向组合治疗提供了一个强大的策略.
- 同时准MYC和诱导ICD重塑免疫TME以增强抗瘤反应.
- 这种方法有望改善MYC放大骨髓瘤患者的临床结果.
更多相关视频
08:04Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
Published on: March 18, 2014
12.8K
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
10.9K
相关概念视频
02:17The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
01:27Tumor Immunotherapy
464
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464